Korify Capital
Venture capitalSeries A–Late Stage · 3 people tracked
Investment thesis
Korify Capital invests in companies advancing longevity and mental health, aiming to help people live long, healthy, and fulfilled lives. The firm backs unique, pioneering approaches led by strong teams that are redefining their sectors. Its investment focus is on Series A through Series C rounds in companies that have demonstrated strong traction, achieved proof of concept, and are positioned to become future leaders in their fields.
Source: firm website, verified Aug 3, 2026.
Team · 3 people
from the firm's website & public directories
What they invest in
from 13 of 15 portfolio companiesBiotech ×11Longevity ×7Healthtech ×5Deep Tech ×4Medical Devices ×3Digital Health ×2AI & Machine Learning ×1Consumer ×1
HQs:United States×6
Investments · 15 tracked
founders shown can be your intro pathBy year:2026 · 12021 · 12 dated
Alto Neuroscience is a clinical-stage biopharmaceutical company developing biology-driven medicines for neuropsychiatric conditions, using measurements of brain biology to predict clinical response and identify patients likely to benefit from its drug candidates.
BiotechDigital HealthMental HealthMountain View, US
Amit Etkin(Founder)Adam Savitz(Executive Officer)Nicholas C. Smith(Executive Officer)Michael Hanley(Executive Officer)Aaron Weaver(Director)Po Yu (Jeff) Chen(Director)
Co-investorsAble PartnersAlpha Wave GlobalInVivium CapitalK2 HealthVenturesVivo CapitalWhat If Ventures+1 more
Aera builds an AI-powered platform that structures and analyzes fragmented patient medical data in real time, using its Aera Health Data Format, a Healthplan Builder, and Digital Twin modeling to help doctors deliver proactive, personalized care.
AI & Machine LearningDigital HealthHealthtech
Biotech company developing small molecule therapeutics to activate cellular quality control machinery for treating neurodegenerative diseases.
Booster Therapeutics develops small-molecule medicines that directly activate the cell's 20S proteasome to restore protein quality-control and clear disease-causing proteins, using its structure-based DGRADX platform combining high-throughput screening, X-ray crystallography, and computational tools.
BiotechDeep TechLongevity
Diogo R. Feleciano(Co-Founder & CSO)Darci J. Trader(Scientific Co-Founder / Advisor)João Ribas(Interim-CBO)
Co-investorsApollo Health VenturesNovo Holdings
Distributed development company building a pipeline of therapies to prevent age-related illness and extend healthspan.
Cambrian Biopharma develops medicines targeting metabolic pathways that decline with age, aiming to treat and eventually prevent chronic metabolic disease and extend healthspan.
BiotechHealthtechLongevityMedical DevicesNew York, US
James G. Peyer(Executive Officer, Director)James Peyer(CEO, Founder, Board Director)Mark Nuttall(Chief Business Officer)inRuth Thieroff-Ekerdt(Chief Medical Officer)inWilliam DeVaul(Executive Officer)Bill DeVaul(Chief Legal Officer)
Co-investorsCatalio Capital Management, LPFuture VenturesKhosla VenturesSprint VcStrawberry Creek Venturesatai Life Sciences
Centenara Labs is a longevity-focused drug discovery company that translates research on the biology of aging into therapies intended to improve healthy aging and extend lifespan.
BiotechHealthtechLongevity
Christian Angermayer(Founder)in
Co-investorsCatalio Capital Management, LPP53 Invest
Cleara Biotech is a biopharmaceutical R&D company developing peptide-based therapies that selectively eliminate cells with impaired p53 signaling, targeting cancer and chronic diseases.
BiotechLongevityMedical Devices
Co-investorsCoastCapCurie Capital
Gameto develops cell therapy and reproductive technologies to treat infertility and improve women's health outcomes.
BiotechFemTechHealthtechMedical DevicesAustin, US
Dina Turner(Co-founder & Chief Executive Officer)inMartin Varsavsky(Co-founder & Chairman)inDina Radenkovic(Executive Officer, Director)
BoardDusan Perovic(Director)inDylan Morris(Director)Maryanna Saenko(Director)in
Co-investorsBold Capital PartnersFuture VenturesIngeborg InvestmentsJazzya InvestmentsLux CapitalMyelin VC+11 more
BiotechSt. Petersburg, US
Christopher Shepard(Executive Officer, Director)Jarod Rutledge(Director)
BoardNils Regge(Director)
Nula Therapeutics develops targeted small-molecule medicines that correct how the nuclear envelope regulates gene expression and cellular function.
BiotechDeep TechLongevity
Samsara Therapeutics develops small-molecule therapeutics that activate autophagy to slow the progression of age-related neurodegenerative diseases such as ALS, Parkinson's, and Charcot-Marie-Tooth disease.
BiotechDeep TechLongevityBoston, US
Co-investorsApollo Health VenturesCoastCap
Biopharmaceutical company developing first-in-class therapeutics for rare genetic and neurodegenerative diseases with a focus on autophagy enhancement.
BiotechLewes, US
Jens Eckstein(Executive Officer, Director)
Storypod makes audio players and screen-free content for young children, including the Eddi all-in-one sleep, play, and learning system and Craftie/Token audio collections featuring licensed stories such as Eric Carle's "The Very Hungry Caterpillar." Its products combine sound machine and nightlight functions with expert-designed learning content aimed at early childhood development.
ConsumerEdTechHardware
Co-investorsMiami Angels
Exits · 1
IPOs and acquisitions across the tracked portfolioAlto NeuroscienceNYSE: ANRO
Portfolio news
latest coverage across their companies
Alto Neuroscience · finance.yahoo.com · Aug 16, 2026
Gameto · smartcompany.com.au · Jul 17, 2026
Frequently asked questions
- How many investments has Korify Capital made?
- Korify Capital has 15 tracked investments, including 1 dated in the last 24 months.
- What stage does Korify Capital invest at?
- Korify Capital invests at the Series A, Series B, Series C, Late Stage stages.
- What sectors does Korify Capital focus on?
- Korify Capital focuses on AI & Machine Learning, Biotech, Healthtech, Longevity, Mental Health.
- Who does Korify Capital co-invest with?
- Korify Capital most often shares deals with Catalio Capital Management, LP, CoastCap, Future Ventures, among 26 tracked co-investors.
Images
Similar investors
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
MPM BioImpact combines 30+ years of biotech venture capital expertise with impact investing and public market experience, managing early-stage venture funds, private/public impact funds, and a public equities fund focused on transforming patient outcomes.
JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.
Equitage Ventures is an early-stage investor providing capital, distribution, and strategic guidance to entrepreneurs addressing the physical, mental, spiritual, and social needs of older adults across the senior care continuum.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.